Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rγnull mice
about
Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in TransplantationRegulatory T cell-derived exosomes: possible therapeutic and diagnostic tools in transplantationIslet cell transplant and the incorporation of Tregs.Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells.Humanized Mouse Models of Clinical Disease.Increase in Peripheral Blood Intermediate Monocytes is Associated with the Development of Recent-Onset Type 1 Diabetes Mellitus in Children.Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives.Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model.Accessory cells for β-cell transplantation.Humanized Mouse Models for Transplant Immunology.Treg therapy in transplantation: a general overview.Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation.Humanized mice: A brief overview on their diverse applications in biomedical research.Regulatory T-cell therapy in liver transplantation.Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics.Coxsackievirus B4 as a Causative Agent of Diabetes Mellitus Type 1: Is There a Role of Inefficiently Treated Drinking Water and Sewage in Virus Spreading?A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials.
P2860
Q26784460-FD0DD4CB-BBFC-4E29-9373-7EC0081F9A22Q34454926-7C37163A-5C5E-4B2D-ADD2-E1BA2B8A74E1Q34729072-4EC11D56-0B5B-4D47-BB5E-4FCA960EB626Q36420758-F545245F-AB5A-452A-8239-EDB59F9FD38AQ37614202-7494771A-E283-4BE0-B2EE-AF4A54EA514BQ37675899-1E424044-E2BB-4AF1-86BE-0BDAE17CF870Q38290087-60583CF1-47AC-44CE-AB4C-88F7E4517981Q38365254-AB33AF17-7ECB-4E39-AD55-1377A17D5EA2Q38411332-DC054CAD-1906-426D-A4AE-503D777D08F1Q38569790-EF3F91AB-B04B-4A97-9266-7D788B54D4B1Q38640208-2056D2CE-B354-4E75-A270-1D2D74C81740Q38778543-7D011EDA-35B6-4B4C-A992-223924E45313Q38918455-33ECC65A-0860-465F-8A2A-554B66265362Q39329450-FD828AF0-897C-45C0-9BA6-3634476BB77DQ39368910-6BC9E75A-F0D0-4D02-AFDB-C42CEC46B175Q41537754-5451B66F-3ED1-4463-B887-FCB01F29DB6CQ41918477-5482C647-727D-4FD0-8DB3-E7478EBE6AD7Q52725822-AB55D487-2D66-4DE6-9837-10E7476975A5
P2860
Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rγnull mice
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ex vivo expanded human regulat ...... ituted NOD-scid IL2rγnull mice
@ast
Ex vivo expanded human regulat ...... ituted NOD-scid IL2rγnull mice
@en
Ex vivo expanded human regulat ...... ituted NOD-scid IL2rγnull mice
@nl
type
label
Ex vivo expanded human regulat ...... ituted NOD-scid IL2rγnull mice
@ast
Ex vivo expanded human regulat ...... ituted NOD-scid IL2rγnull mice
@en
Ex vivo expanded human regulat ...... ituted NOD-scid IL2rγnull mice
@nl
prefLabel
Ex vivo expanded human regulat ...... ituted NOD-scid IL2rγnull mice
@ast
Ex vivo expanded human regulat ...... ituted NOD-scid IL2rγnull mice
@en
Ex vivo expanded human regulat ...... ituted NOD-scid IL2rγnull mice
@nl
P2093
P2860
P1433
P1476
Ex vivo expanded human regulat ...... ituted NOD-scid IL2rγnull mice
@en
P2093
Giovanna Lombardi
Guocai Huang
Robert Lechler
Vincenzo Mirenda
P2860
P304
P356
10.1371/JOURNAL.PONE.0090387
P407
P577
2014-01-01T00:00:00Z